R Scott Greer Nektar Therapeutics (NKTR) insider trading activity

NKTR Quotes by TradingView

R Scott Greer is Director of NEKTAR THERAPEUTICS. Currently has a direct ownership of 303,574 shares of NKTR, which is worth approximately $355,181. The most recent transaction as insider was on Sep 16, 2022, when has been sold 10,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 304K
0% 3M change
0% 12M change
Total Value Held $355,181

R SCOTT GREER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2022
BUY
Grant, award, or other acquisition
-
10,200 Added 3.25%
303,574 Common Stock
Nov 09 2021
BUY
Exercise of conversion of derivative security
$160,000 $12.8 p/Share
12,500 Added 4.09%
293,374 Common Stock
Sep 22 2021
BUY
Grant, award, or other acquisition
-
10,200 Added 3.5%
280,874 Common Stock
Aug 31 2021
BUY
Exercise of conversion of derivative security
$571,500 $12.7 p/Share
45,000 Added 14.26%
270,674 Common Stock
Jan 05 2021
BUY
Exercise of conversion of derivative security
$552,000 $13.8 p/Share
40,000 Added 15.06%
225,674 Common Stock

Also insider at

INGN
Inogen Inc Healthcare
Director
RSG

R Scott Greer

Director
San Francisco, CA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTR